Humana Inc. (NYSE:HUM) is scheduled to be posting its quarterly earnings results before the market opens on Wednesday, November 8th. Analysts expect Humana to post earnings of $3.25 per share for the quarter.

Shares of Humana Inc. (NYSE:HUM) opened at $254.48 on Tuesday. The company has a market cap of $37,096.12, a PE ratio of 22.30, a PEG ratio of 1.66 and a beta of 0.91. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.65 and a current ratio of 1.65. Humana Inc. has a one year low of $165.52 and a one year high of $264.56.

The business also recently announced a quarterly dividend, which will be paid on Friday, January 26th. Stockholders of record on Friday, December 29th will be paid a dividend of $0.40 per share. The ex-dividend date of this dividend is Thursday, December 28th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.63%. Humana’s dividend payout ratio is currently 13.06%.

A number of analysts have recently commented on the stock. ValuEngine raised shares of Humana from a “hold” rating to a “buy” rating in a research note on Friday, September 1st. Credit Suisse Group assumed coverage on shares of Humana in a research note on Thursday, November 2nd. They set a “neutral” rating and a $256.00 target price for the company. UBS AG reissued a “neutral” rating and set a $250.00 target price (up previously from $237.00) on shares of Humana in a research note on Wednesday, August 9th. BidaskClub raised shares of Humana from a “sell” rating to a “hold” rating in a research note on Thursday, August 10th. Finally, Cantor Fitzgerald reissued a “neutral” rating and set a $223.00 target price (up previously from $200.00) on shares of Humana in a research note on Thursday, August 3rd. Thirteen research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. The stock has an average rating of “Hold” and an average price target of $253.71.

In other Humana news, insider Elizabeth D. Bierbower sold 9,786 shares of the stock in a transaction that occurred on Friday, September 1st. The shares were sold at an average price of $259.00, for a total transaction of $2,534,574.00. Following the sale, the insider now directly owns 18,042 shares in the company, valued at approximately $4,672,878. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, VP Timothy S. Huval sold 7,803 shares of the stock in a transaction that occurred on Friday, September 1st. The stock was sold at an average price of $258.14, for a total transaction of $2,014,266.42. Following the sale, the vice president now owns 8,831 shares in the company, valued at $2,279,634.34. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 55,595 shares of company stock worth $14,133,706. 0.80% of the stock is owned by company insiders.

ILLEGAL ACTIVITY WARNING: This piece of content was posted by Watch List News and is the sole property of of Watch List News. If you are viewing this piece of content on another publication, it was stolen and republished in violation of US & international copyright & trademark law. The original version of this piece of content can be viewed at https://www.watchlistnews.com/humana-inc-hum-set-to-announce-quarterly-earnings-on-wednesday/1684049.html.

About Humana

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Earnings History for Humana (NYSE:HUM)

Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.